FY2024 EPS Estimates for CG Oncology Lifted by HC Wainwright
Research analysts at HC Wainwright raised their FY2024 earnings estimates for shares of CG Oncology in a research note issued ...
The Globe and Mail13h
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
In this trial, PLN-101095 is being tested as monotherapy and in combination with pembrolizumab in patients with solid tumors that are resistant to immune checkpoint inhibitors. Preliminary data is ...